Triple
T1169483
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | spinal muscular atrophy |
E24880
|
entity |
| Predicate | treatedBy |
P4714
|
FINISHED |
| Object |
risdiplam
Risdiplam is an oral small-molecule drug used to treat spinal muscular atrophy by increasing production of functional survival motor neuron (SMN) protein.
|
E133682
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a494082a7c819095004f423f294a64 |
elicitation | completed |
| NER | batch_69a4bf13ab648190931dea78202096e4 |
ner | completed |
| NED1 | batch_69ac668562788190ac5f8d081a46b2ee |
ned_source_triple | completed |
| NED2 | batch_69ac6826ef4c81909fc077bfba22b16f |
ned_description | completed |
| NEDg | batch_69ac67a07f28819096fcd7b767e07a63 |
nedg | completed |
Created at: March 1, 2026, 7:45 p.m.